Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta-analysis

Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):235-42. doi: 10.1002/ajmg.b.30986.

Abstract

Conflicting results have been reported as to whether genetic variations (Val66Met and C270T) of the brain-derived neurotrophic factor gene (BDNF) confer susceptibility to Alzheimer's disease (AD). We genotyped these polymorphisms in a Japanese sample of 657 patients with AD and 525 controls, and obtained weak evidence of association for Val66Met (P = 0.063), but not for C270T. After stratification by sex, we found a significant allelic association between Val66Met and AD in women (P = 0.017), but not in men. To confirm these observations, we collected genotyping data for each sex from 16 research centers worldwide (4,711 patients and 4,537 controls in total). The meta-analysis revealed that there was a clear sex difference in the allelic association; the Met66 allele confers susceptibility to AD in women (odds ratio = 1.14, 95% CI 1.05-1.24, P = 0.002), but not in men. Our results provide evidence that the Met66 allele of BDNF has a sexually dimorphic effect on susceptibility to AD.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / genetics*
  • Base Sequence
  • Brain-Derived Neurotrophic Factor / genetics*
  • Case-Control Studies
  • DNA Primers
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Male
  • Methionine / genetics*
  • Sex Characteristics*
  • Valine / genetics*

Substances

  • Brain-Derived Neurotrophic Factor
  • DNA Primers
  • Methionine
  • Valine